Rehabilitation Characteristics and Outcomes for Lung Transplantation for COVID-19: A Case Series.

Acute Care COVID-19 Cardiovascular System Critical Care Lung Transplantation Rehabilitation Respiratory System

Journal

Physical therapy
ISSN: 1538-6724
Titre abrégé: Phys Ther
Pays: United States
ID NLM: 0022623

Informations de publication

Date de publication:
04 05 2023
Historique:
received: 29 03 2022
revised: 29 07 2022
accepted: 02 01 2023
medline: 1 6 2023
pubmed: 30 5 2023
entrez: 30 5 2023
Statut: ppublish

Résumé

Severe coronavirus disease 2019 (COVID-19) can result in irreversible lung damage, with some individuals requiring lung transplantation. The purpose of this case series is to describe the initial experience with the rehabilitation and functional outcomes of 9 patients receiving a lung transplant for COVID-19. Nine individuals, ranging in age from 37 to 68 years, received bilateral orthotopic lung transplantation (BOLT) for COVID-19 between December 2020 and July 2021. Rehabilitation was provided before and after the transplant, including in-hospital rehabilitation, postacute care inpatient rehabilitation, and outpatient rehabilitation. Progress with mobility was limited in the pretransplant phase despite rehabilitation efforts. Following transplantation, 2 individuals expired before resuming rehabilitation, and 2 others had complications that delayed their progress. The remaining 5 experienced clinically important improvements in mobility and walking capacities. Considerable rehabilitation resources are required to care for individuals both before and after BOLT for COVID-19. Rehabilitation can have a profound impact on both functional and clinical outcomes for this unique patient population. There is limited literature on the rehabilitation efforts and outcomes for patients who received BOLT for COVID-19. Occupational therapists and physical therapists play an important role during the pretransplant and posttransplant recovery process for this novel patient population. Patients with a bilateral orthotopic lung transplant due to COVID-19 require a unique rehabilitation process. They have significant difficulties with activities of daily living and functional mobility across the pretransplant and posttransplant continuum of care, but progressive gains in functional performance may be possible with a comprehensive multidisciplinary rehabilitation program.

Identifiants

pubmed: 37249530
pii: 7069113
doi: 10.1093/ptj/pzad026
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the American Physical Therapy Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Malachy J Clancy (MJ)

Department of Occupational & Physical Therapy, Good Shepherd Penn Partners, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Joe Adler (J)

Department of Occupational & Physical Therapy, Good Shepherd Penn Partners, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Michael A Tevald (MA)

Department of Physical Therapy, Arcadia University, Glenside, Pennsylvania, USA.

Derek Zaleski (D)

Department of Occupational & Physical Therapy, Good Shepherd Penn Partners, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Lindsay Fluehr (L)

Department of Occupational & Physical Therapy, Good Shepherd Penn Partners, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Carol Wamsley (C)

Penn Institute for Rehabilitation Medicine, Good Shepherd Penn Partners, Philadelphia, Pennsylvania, USA.

Christian A Bermudez (CA)

Division of Cardiac Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Maria M Crespo (MM)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Priya Balar (P)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Michelle L Oyster (ML)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Andrew M Courtwright (AM)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Joshua M Diamond (JM)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH